
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
Q4 revenue of $32.3 million, increasing 14% year-over-year Q4 gross profit increased 23% year-over-year to $22.0 million with gross margin of 68% Company generated revenue from 48 DAAP deals in 2024, up from 24 in 2023 WALTHAM, Mass., March 12, 2025 (GLOBE …